Michele Baccarani

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications

Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.

Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.

Journal: Leukemia
Published: January 14, 2022

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study.

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study.

Journal: Haematologica
Published: October 13, 2021

Quality of Life Improvements in Patients With Chronic Myeloid Leukemia After Stopping Long-Term Therapy: Who Can Benefit the Most?

Quality of Life Improvements in Patients With Chronic Myeloid Leukemia After Stopping Long-Term Therapy: Who Can Benefit the Most?

Journal: Journal of the National Cancer Institute
Published: August 24, 2021

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network.

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network.

Journal: Frontiers in oncology
Published: July 10, 2021

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.

Journal: Blood advances
Published: March 22, 2021

Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors.

Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors.

Journal: Leukemia
Published: January 07, 2021

Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.

Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.

Journal: Frontiers in oncology
Published: December 07, 2020

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia.

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia.

Journal: Leukemia & lymphoma
Published: November 06, 2020

Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: October 27, 2020

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.

Journal: Leukemia
Published: September 11, 2020

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.

Journal: Cancer medicine
Published: August 19, 2020

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives.

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives.

Journal: Journal of clinical medicine
Published: May 22, 2020
Showing 1-12 of 155

Last Updated: 09/26/2026